Products - Structural heart defects | Topic

Showing 30 products

Date | Title

Acoramidis for treating transthyretin amyloidosis with cardiomyopathy (TA1121)
Product type:
Guidance
Programme:
Technology appraisal guidance
Published:
14 January 2026
Aficamten for treating symptomatic non-obstructive hypertrophic cardiomyopathy [ID6668]
Status:
Awaiting development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Aficamten for treating symptomatic obstructive hypertrophic cardiomyopathy [ID6575]
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
5 August 2026
Atrial fibrillation and heart valve disease: self-monitoring coagulation status using point-of-care coagulometers (the CoaguChek XS system) (HTG353)
Product type:
Guidance
Programme:
HealthTech guidance
Last updated:
19 December 2017
Published:
24 September 2014
Bioprosthetic or native Aortic Scallop Intentional Laceration to prevent Iatrogenic Coronary Artery obstruction (BASILICA)
Status:
Topic prioritisation
Programme:
Interventional procedures guidance
Expected publication date:
TBC
Cor-Knot for tying suture knots in valve surgery (MIB206)
Product type:
Advice
Programme:
Medtech innovation briefing
Published:
10 March 2020
Cor-Knot for tying suture knots in valve surgery
Status:
Topic prioritisation
Programme:
Medical technologies guidance
Expected publication date:
TBC
Detecting, managing and monitoring haemostasis: viscoelastometric point‑of‑care testing (ROTEM, TEG and Sonoclot systems) (HTG348)
Product type:
Guidance
Programme:
HealthTech guidance
Published:
20 August 2014
DMD Care UK’s guideline on cardiac care of children with dystrophinopathy and females carrying DMD-gene variations: NICE review (NR1)
Product type:
Advice
Programme:
NICE review
Published:
5 September 2025
Elamipretide for treating Barth syndrome in people of any age [ID6545]
Status:
Awaiting development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Endovascular Arch Repair
Status:
Topic prioritisation
Programme:
Interventional procedures guidance
Expected publication date:
TBC
Eplontersen for treating transthyretin-related amyloidosis cardiomyopathy [TSID12015]
Status:
Awaiting development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Heart valve disease in adults
Status:
Awaiting development
Expected publication date:
TBC
Heart valve disease presenting in adults: investigation and management (NG208)
Product type:
Guidance
Programme:
NICE guideline
Published:
17 November 2021
Heart valve disease presenting in adults: investigation and management - transcatheter aortic valve implantation (TAVI) to treat aortic stenosis (update)
Status:
In development
Programme:
NICE guideline
Expected publication date:
TBC
Interventional Correction of Superior Sinus Venosus Defect and Partial Anomalous Pulmonary Venous Drainage
Status:
Awaiting development
Programme:
Interventional procedures guidance
Expected publication date:
TBC
Intravascular Lithotripsy-Enabled Vascular Access for Transfemoral Transcatheter Aortic Valve Replacement
Status:
Topic prioritisation
Programme:
Interventional procedures guidance
Expected publication date:
TBC
Mavacamten for treating symptomatic non-obstructive hypertrophic cardiomyopathy [ID6523]
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Mavacamten for treating symptomatic obstructive hypertrophic cardiomyopathy (TA913)
Product type:
Guidance
Programme:
Technology appraisal guidance
Published:
6 September 2023
microINR for anticoagulation therapy (MIB257)
Product type:
Advice
Programme:
Medtech innovation briefing
Published:
21 April 2021
microINR for anticoagulation therapy MT592 (MIB257)
Status:
Topic prioritisation
Programme:
Medical technologies guidance
Expected publication date:
TBC
Off-pump minimal access mitral valve repair by artificial chordae insertion to treat mitral regurgitation
Status:
In development
Programme:
Interventional procedures guidance
Expected publication date:
25 February 2026
Prophylaxis against infective endocarditis: antimicrobial prophylaxis against infective endocarditis in adults and children undergoing interventional procedures (CG64)
Product type:
Guidance
Programme:
Clinical guideline
Last updated:
8 July 2016
Published:
17 March 2008
Tafamidis for treating transthyretin amyloidosis with cardiomyopathy (TA984)
Product type:
Guidance
Programme:
Technology appraisal guidance
Published:
19 June 2024
The hTEE system for transoesophageal echocardiographic monitoring of haemodynamic instability (MIB7)
Product type:
Advice
Programme:
Medtech innovation briefing
Published:
11 August 2014
Transcatheter tricuspid valve implantation for symptomatic severe tricuspid regurgitation
Status:
In development
Programme:
Interventional procedures guidance
Expected publication date:
25 February 2026
Transcatheter Tricuspid Valve Replacement
Status:
Topic prioritisation
Programme:
Interventional procedures guidance
Expected publication date:
TBC
Transcatheter valve-in-valve implantation for the treatment of Tricuspid valve
Status:
Topic prioritisation
Programme:
Interventional procedures guidance
Expected publication date:
TBC
Trans-septal transcatheter mitral valve-in-valve implantation for failed surgical mitral valve bioprosthesis
Status:
Topic prioritisation
Programme:
Interventional procedures guidance
Expected publication date:
TBC
Vutrisiran for treating transthyretin amyloidosis with cardiomyopathy (TA1115)
Product type:
Guidance
Programme:
Technology appraisal guidance
Published:
10 December 2025

Structural heart defects Products

Filter

Product type

Guidance programme

Advice programme

Status

New and updated

Showing 30 products

Acoramidis for treating transthyretin amyloidosis with cardiomyopathy (TA1121)

Aficamten for treating symptomatic non-obstructive hypertrophic cardiomyopathy [ID6668]

Aficamten for treating symptomatic obstructive hypertrophic cardiomyopathy [ID6575]

Atrial fibrillation and heart valve disease: self-monitoring coagulation status using point-of-care coagulometers (the CoaguChek XS system) (HTG353)

Bioprosthetic or native Aortic Scallop Intentional Laceration to prevent Iatrogenic Coronary Artery obstruction (BASILICA)

Cor-Knot for tying suture knots in valve surgery (MIB206)

Cor-Knot for tying suture knots in valve surgery

Detecting, managing and monitoring haemostasis: viscoelastometric point‑of‑care testing (ROTEM, TEG and Sonoclot systems) (HTG348)

DMD Care UK’s guideline on cardiac care of children with dystrophinopathy and females carrying DMD-gene variations: NICE review (NR1)

Elamipretide for treating Barth syndrome in people of any age [ID6545]

Endovascular Arch Repair

Eplontersen for treating transthyretin-related amyloidosis cardiomyopathy [TSID12015]

Heart valve disease in adults

Heart valve disease presenting in adults: investigation and management (NG208)

Heart valve disease presenting in adults: investigation and management - transcatheter aortic valve implantation (TAVI) to treat aortic stenosis (update)

Interventional Correction of Superior Sinus Venosus Defect and Partial Anomalous Pulmonary Venous Drainage

Intravascular Lithotripsy-Enabled Vascular Access for Transfemoral Transcatheter Aortic Valve Replacement

Mavacamten for treating symptomatic non-obstructive hypertrophic cardiomyopathy [ID6523]

Mavacamten for treating symptomatic obstructive hypertrophic cardiomyopathy (TA913)

microINR for anticoagulation therapy (MIB257)

microINR for anticoagulation therapy MT592 (MIB257)

Off-pump minimal access mitral valve repair by artificial chordae insertion to treat mitral regurgitation

Prophylaxis against infective endocarditis: antimicrobial prophylaxis against infective endocarditis in adults and children undergoing interventional procedures (CG64)

Tafamidis for treating transthyretin amyloidosis with cardiomyopathy (TA984)

The hTEE system for transoesophageal echocardiographic monitoring of haemodynamic instability (MIB7)

Transcatheter tricuspid valve implantation for symptomatic severe tricuspid regurgitation

Transcatheter Tricuspid Valve Replacement

Transcatheter valve-in-valve implantation for the treatment of Tricuspid valve

Trans-septal transcatheter mitral valve-in-valve implantation for failed surgical mitral valve bioprosthesis

Vutrisiran for treating transthyretin amyloidosis with cardiomyopathy (TA1115)